Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition

Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition

US Patent 11077108 · Granted Aug 3, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for increasing muscle mass and oxidative metabolism2025
Compositions and methods for increasing muscle mass and oxidative metabolism2025
Deformable nano-scale vehicles (DNVS) for trans-blood brain barrier, trans-mucos2025
Deformable nano-scale vehicles (DNVS) for trans-blood brain barrier, trans-mucos2025
Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau2024
Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau2024
APP specific bace inhibitors (ASBIs) and uses thereof2024
Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau2022
Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau2022
Tropinol esters and related compounds to promote normal processing of APP2022
Small molecules that enable cartilage rejuvenation2022
3D-exoquant method for the analysis of surface molecules and quantification of t2022